ERBB2 and breast cancer: In contrast, a Korean study reported more frequently diagnosed HER2‐overexpressing subtype in the LIQ and triple‐negative subtype in the UOQ zone, which appeared generally consistent with our findings on the advanced stage breast cancer in LIQ and UOQ.46 Collectively, research on breast cancer tumor location and its clinical stage and molecular subtypes has not reached all consistent findings.